Houssein El Hajj: Is the 2 cm Cutoff Enough for Fertility-Sparing Surgery in Early Cervical Cancer?
Houssein El Hajj, Gynecologic Oncologist at Gustave Roussy and President of the European Network of Young Gynae Oncologists, shared a post on LinkedIn about a paper he co-authored with colleagues published in the International Journal of Gynecological Cancer։
“Is a 2 cm cutoff really precise enough when considering fertility-sparing surgery for early cervical cancer?
Pleased to share our new commentary in the International Journal of Gynecological Cancer: ‘Is conization with lymph node dissection safe for FIGO 2018 stage IB1 cervical cancer measuring 1 to 2 cm?’
Prospective data from ConCerv and GOG-278 have strengthened the case for surgical de-escalation in carefully selected patients. But an important question remains: should a sub-centimeter tumor and a tumor approaching 2 cm really be considered equivalent?
In this commentary, we discuss evidence suggesting that tumor size within the 1–2 cm range and lymphovascular space invasion may be important determinants of recurrence risk, while increasing surgical radicality itself may not necessarily improve oncologic outcomes.
The goal is not to move automatically toward more radical surgery, but rather toward better risk stratification and more individualized fertility-sparing decision-making.
More prospective data is needed to identify which patients with 10–20 mm tumors can safely undergo conization and lymph-node assessment, and whether some may benefit from closer surveillance.
Read the commentary.”
Title: Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
Authors: Houssein El Hajja, Sébastien Gouy, Elaine Limkin, Stéphanie Scherier, Philippe Morice.
You can read the Full Article in the International Journal of Gynecological Cancer․

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF
-
Oct 29, 2026, 14:59Jodi Neuhauser: We Need a Graveyard of Women’s Health Companies (In a Positive Way)
-
Oct 29, 2026, 14:56Resa Nabor: An Inspiring Story of Strength, Courage, and Never Giving Up
-
Oct 29, 2026, 14:54Robert Borowczyk: What Happens After a Failed IVF Cycle?
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
